Champions Oncology (CSBR) Market Capitalization (2011 - 2026)

Champions Oncology has reported Market Capitalization for 16 years, with the latest figure at $82.8 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 15.98% year-over-year to $82.8 million in Q2 2026; TTM through Apr 2026 was $82.8 million, a 15.98% decrease from a year earlier, with the FY2026 full-year figure at $82.8 million, down 15.98% from the prior year.
• Market Capitalization was $82.8 million for Q2 2026 at Champions Oncology, down from $101.5 million in the prior quarter.
• The five-year high for Market Capitalization was $150.6 million in Q1 2025, with the low at $53.6 million in Q4 2024.
• Average Market Capitalization over 5 years is $88.2 million, with a median of $87.4 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization sank 48.6% in 2023, then jumped 90.71% in 2025.
• Over 5 years, Market Capitalization stood at $94.1 million in 2022, then slipped by 21.12% to $74.2 million in 2023, then retreated by 27.83% to $53.6 million in 2024, then jumped by 77.33% to $95.0 million in 2025, then dropped by 12.86% to $82.8 million in 2026.
• The last three Market Capitalization figures came in at $82.8 million (Q2 2026), $101.5 million (Q1 2026), and $95.0 million (Q4 2025), per Business Quant data.